Loading chart…
CLOSED
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules.
Windlas Biotech Limited (WINDLAS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The WINDLAS share price is ₹1,022.00 (-1.37% today), with a market capitalisation of ₹21B and a price-to-earnings (P/E) ratio of 32.7. MarketRipple tracks the WINDLAS investment thesis, the ripple-chain impact of market events on Windlas Biotech Limited, and the Healthcare sector outlook.
Open
₹1,038.50
High
₹1,042.20
Low
₹1,011.70
Prev. Close
₹1,036.20
52W High
₹1,181.90
52W Low
₹697.40
Day range
₹1,011.70–₹1,042.20
52-week range
₹697.40–₹1,181.90
Volume
78K
P/E
32.7
ROE
11.4%
D/E
0.06
Margin
7.1%
Windlas Biotech Limited (NSE: WINDLAS) is currently trading at ₹1,022.00 (-1.37%).
Windlas Biotech Limited's market capitalization is ₹21B.
Windlas Biotech Limited's price-to-earnings (P/E) ratio is 32.7.
Windlas Biotech Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).